Stewardship Advisors’s AbbVie ABBV Stock Holding History

Stewardship Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Sell	931 -14	-1%	-$3.01K	0.05%	159
2026 Q1	$206K	Sell	945 -77	-8%	-$17.1K	0.05%	162
2025 Q4	$234K	Buy	1,022 +71	+7%	+$16.2K	0.05%	141
2025 Q3	$220K	Buy	+951	New	+$194K	0.05%	144
2025 Q2	–	Sell	-1,069	Closed	-$224K	–	152
2025 Q1	$224K	Buy	+1,069	New	+$208K	0.06%	132

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Stewardship Advisors's ABBV Position: Q2 2026 in Review

Stewardship Advisors reduced its AbbVie (ABBV) stake by 1.5% in Q2 2026, selling an estimated $3.01K and leaving 931 shares worth $234K. The position accounts for 0.05% of the portfolio, ranked #159.

Stewardship Advisors first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 2,085 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Stewardship Advisors held 931 shares of AbbVie worth $234K as of Q2 2026.
Stewardship Advisors sold 14 AbbVie shares in Q2 2026, an estimated $3.01K.
AbbVie made up 0.05% of Stewardship Advisors's portfolio in Q2 2026, its #159 holding.
Stewardship Advisors first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
2,085 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stewardship Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.